Provided by Tiger Trade Technology Pte. Ltd.

Rhythm Pharmaceuticals Inc.

75.82
-6.0800-7.42%
Post-market: 75.820.00000.00%19:15 EDT
Volume:1.43M
Turnover:110.19M
Market Cap:5.18B
PE:-24.41
High:83.65
Open:81.00
Low:75.44
Close:81.90
52wk High:122.20
52wk Low:45.91
Shares:68.29M
Float Shares:55.48M
Volume Ratio:0.99
T/O Rate:2.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1057
EPS(LYR):-3.1100
ROE:-90.45%
ROA:-27.51%
PB:37.23
PE(LYR):-24.38

Loading ...

Mar 27, 2026

Major Issues Report

Form 8-K - Current report
Mar 20, 2026

Major Issues Report

Form 8-K - Current report
Mar 17, 2026

Major Issues Report

Form 8-K - Current report
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 02, 2026

Major Issues Report

Form 8-K - Current report
Feb 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 16, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 09, 2026

Major Issues Report

Form 8-K - Current report
Dec 19, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2025

Major Issues Report

Form 8-K - Current report
Nov 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Major Issues Report

Form 8-K - Current report